TCGX Acquisition Corp. II (Stock-Only)

Note: TCGX Acquisition Corp. II is offering only stock in its SPAC IPO. A typical SPAC IPO consists of units, with each unit made up of a share of stock plus a warrant or a right, or a fraction of a warrant or a right – or both – with the right to receive a […]

September 28, 2026 Read More

TFP Group (The)

(Incorporated in Bermuda) Our mission is to be the leading originator and allocator of (re)insurance risk, combining high-conviction underwriting and portfolio solutions powered by technology, data and AI, to create enduring partnerships and deliver better outcomes for (re)insureds, brokers, and Capacity Providers. Who We Are TFP is the world’s largest independent MGA. We are a […]

Read More

City Therapeutics

(Incorporated in Delaware) We are a clinical biotech company focused on developing RNA interference (RNAi) therapeutics to silence disease-relevant proteins. We are focused on thromboembolic diseases, Type 1 Stargardt disease, and anemia associated with chronic disease. Led by pioneers and experts in the field of RNAi, we have made rapid progress since founding our company […]

September 24, 2026 Read More

Bluerock Acquisition Corp. II

(Incorporated in the Cayman Islands) We are a newly established blank check company. We are affiliated with Bluerock, an alternative asset manager. We intend to focus on businesses in sectors such as Web3 (decentralized platforms and digital assets, and data-intensive FinTech infrastructure) that have one or more of the following attributes: robust growth prospectus, recurring […]

Read More

Frazier Life Sciences Acquisition II (Stock-Only)

Note: This is a stock-only SPAC IPO – an exception to the usual structure. A SPAC IPO typically consists of a share of common stock and a warrant or a right to acquire a share (or a fraction of a share) of stock upon the consummation of the SPAC’s initial business combination. We are a […]

Read More

SeeQC

(Incorporated in Delaware) Our vision is to unlock the full potential of quantum computing by enabling scalable, commercially viable quantum systems. We work across the quantum computing ecosystem with hardware developers, integrators, advanced computing partners, manufacturing collaborators and government-supported programs. We believe the path to scale will mirror classical computing, with enabling technologies spanning foundry, […]

September 23, 2026 Read More

GEBE Environmental Technology (Withdrawn)

We are a Singapore-based company that provides environmental improvement and sustainability-focused services. Our co-founders, Joyce Toh and Steven Tay,  are among our primary shareholders. Toh and Tay are also a married couple. Note: Revenue is in U.S. dollars for the 12 months that ended on June 30, 2025.  (Note: GEBE Environmental withdrew its IPO plans […]

September 22, 2026 Read More

Retension Pharmaceuticals

(Incorporated in Delaware) We are a clinical stage biotech developing just one drug candidate, RTN-001, a daily pill for uncontrolled and resistant hypertension. We are evaluating RTN-001 in a Phase 2b trial that began in October 2025. We expect initial data in the first half of 2027. Note: Net loss is for the 12 months […]

Read More

Silicon Valley Acquisition II

(Incorporated in the Cayman Islands) We are a newly organized blank check company. We intend to target businesses in the FinTech, crypto, digital asset, AI infrastructure, energy transition, mobility, technology, consumer, healthcare and mining sectors. Dan Nash is our chairman and CEO. He is the former head of investment banking at Cohen & Company Capital […]

Read More

Iambic Therapeutics

(Incorporated in Delaware) We are a Phase 1 clinical biotech that uses our AI platform to design small molecule cancer drugs. We are evaluating our leading drug candidate, IAM 1363, in a Phase 1/1B trial as a therapy for patients with HER2-altered solid tumors. A registrational trial may begin as soon as 2027.  From the […]

Read More